Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Published inAIDS, vol. 28, no. 15, p. 2231-2239
Publication date2014
Abstract
Keywords
- Adult
- Alleles
- Anti-Retroviral Agents/therapeutic use
- Drug Resistance, Viral
- Female
- Genotyping Techniques/methods
- HIV Infections/virology
- HIV Reverse Transcriptase/genetics
- HIV-1/enzymology/genetics/isolation & purification
- Humans
- Male
- Microbial Sensitivity Tests/methods
- Middle Aged
- Mutation, Missense
- Retrospective Studies
- Treatment Outcome
Affiliation entities
Research groups
Citation (ISO format)
METZNER, Karin J et al. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. In: AIDS, 2014, vol. 28, n° 15, p. 2231–2239. doi: 10.1097/QAD.0000000000000397
Main files (1)
Article (Published version)
Identifiers
- PID : unige:74401
- DOI : 10.1097/QAD.0000000000000397
- PMID : 25036184
ISSN of the journal0269-9370
